NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00931645,Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia,https://clinicaltrials.gov/study/NCT00931645,Auto-LLC 2001,COMPLETED,"Phase III trial evaluating the role of autologous stem cell transplantation in previously untreated patients under 65 years with stage B and C B-cell chronic lymphocytic leukemia.

Endpoints of the trial :

* major : progression free survival at 3 years
* secondary : overall survival, tolerance, prognostic factors according to baseline clinical stage and biological characteristics (IgHv mutational status, expression of ZAP70 and CD38, cytogenetics).",NO,Chronic Lymphocytic Leukemia,PROCEDURE: Autologous stem cell transplantation|PROCEDURE: DHAP rescue and Autologous stem cell transplantation|PROCEDURE: DHAP rescue and F+C,"Progression free survival, 3 year","Overall survival, response after completion of scheduled treatment, tolerance and adverse events, quality of life, prognostic factors for response and survival., 36 months",,"University Hospital, Caen","Direction Générale de la Santé, France",ALL,"ADULT, OLDER_ADULT",PHASE3,241,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,SFGMTC|PHRC,2001-04,2007-12,2008-12,2009-07-02,,2009-07-02,"DBIM Hopital Saint Louis, Paris, 75000, France",
